Guided Screening
33
The following table indicates recommended screening action guidelines: (individual laboratory
policies may differ)
Table 3-4 – Screening Action Guidelines
Situation
BD FocalPoint™
Slide Information
FOV
findings
Summary Action
Any age, all patients
Abnormal
ECC+ / ECC–
ABNORMAL FOV plus Full Slide Review
Cyclic Patient,
Cervix Intact
ECC+ NILM/ECC+ FOV only
Cyclic Patient,
Cervix Intact
ECC+ NILM/ECC– FOV with partial full slide review until
ECC confirmed
Cyclic Patient,
Cervix Intact
ECC– NILM/ECC– FOV only
Post-menopausal
ECC+ NILM,
Atrophy/
ECC
–
Laboratory discretion- may include;
FOV only (ECC uncertain due to
atrophy) or FOV with partial full slide
review until ECC confirmed
Any age, cervix
intact, Limited
Cellularity
ECC+ NILM/ECC+/
Scant
cellularity
FOV followed by cell count along circle
diameter to assess adequacy
NILM/ECC–/
Scant
cellularity
FOV with partial full slide review until
ECC confirmed & cell count along circle
diameter to assess adequacy
Any age, cervix
intact and Organism
ECC+ NILM/Org/
ECC+
FOV only
NILM/Org/
ECC
–
FOV with partial full slide review until
ECC confirmed
Hysterectomy
ECC+
NILM/ECC
–
FOV only
Any age, all patients
Insufficient
Squamous
(see note below)
No FOVs Full Slide Review
Any age, all patients
ECC+/ECC
–
No FOVs Full Slide Review
Process Review
Yellow screen Full Slide Review
Re-Run Pink Screen Full Slide Review
To Next Page
Loading...